Clinical Trial Update: Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results evaluating pomalidomide in HIV-positive patients with skin Kaposi sarcoma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Kaposi Sarcoma

Drugs mentioned

• Pomalyst (pomalidomide)

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Human Immunodeficiency Virus 1 Positive, Skin Kaposi Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2026-02-02